| Code | Description | Claims | Beneficiaries | Total Paid |
| T2046 |
Hospice long term care, room and board only; per diem |
306 |
122 |
$633K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
989 |
607 |
$34K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,124 |
516 |
$22K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
124 |
109 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
154 |
154 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
182 |
170 |
$6K |
| 99306 |
Prolong nursin fac eval 15m |
64 |
48 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
28 |
27 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
28 |
28 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
28 |
28 |
$700.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15 |
14 |
$218.70 |